Nuclear Speckle Protein SRRM2 Co-localized with Pathological Tau (pTauS396) in Neuronal and Glial Cells in Progressive Supranuclear Palsy
ACTA HISTOCHEMICA ET CYTOCHEMICA · 27.06.2026 · 59 (3) · 111-121
DOI: 10.1267/ahc.26-00005 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACTA HISTOCHEMICA ET CYTOCHEMICA, erschienen am 27.06.2026. Verfasst von Faris Hazwan Nazar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Innovation Research Center, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu 520-2192, Japan. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Progressive Supranuclear Palsy (PSP) is a primary 4-repeat tauopathy characterized by progressive motor and cognitive decline. Like other tauopathies, tau misfolding and aggregation are prominent but yield PSP-specific features such as tufted astrocytes and globose neurofibrillary tangles. Emerging evidence suggests that nuclear speckle disassembly and mislocalization of RNA-binding proteins, including serine/arginine repetitive matrix protein 2 (SRRM2), may contribute to disease progression, though SRRM2’s role in PSP remains unclear. To assess its association with tau pathology, we examined SRRM2 distribution in midbrain neurons, as well as in astrocytes from both cortical and midbrain regions, using post-mortem immunohistochemistry, immunofluorescence, and 3D reconstruction. In PSP midbrain, neuronal SRRM2 immunoreactivity was markedly elevated compared to controls and co-localized with pTauS396, with >80% overlap; co-localization strongly correlated with SRRM2 abundance (r = 0.9809, p = 0.0191). 3D analysis revealed heterogeneity across cases (PSP-1 to PSP-4) in aggregate morphology, SRRM2 levels, and tau associations. In tufted astrocytes, pTauS396 signals were detected in PSP-1 cortex and PSP-4 midbrain. SRRM2 was absent or faint, yet 3D imaging revealed near-complete SRRM2–pTauS396 co-localization (99% in PSP-1 cortex, 89% in PSP-4 midbrain), regardless of SRRM2 abundance. These findings highlight SRRM2 association with pTauS396 in tangle of PSP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Innovation Research Center, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu 520-2192, Japan.
- Department of Molecular Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50630, Malaysia.
- Molecular Neuroscience Research Center, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu 520-2192, Japan.
- Department of Pathology, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu 520-2192, Japan.
Zitieren
APA
Nazar, F. H., Arrozi, A. P., Kato, T., Yanagisawa, D., Itoh, Y., Tooyama, I., & Bellier, J. P. (2026). Nuclear Speckle Protein SRRM2 Co-localized with Pathological Tau (pTauS396) in Neuronal and Glial Cells in Progressive Supranuclear Palsy. ACTA HISTOCHEMICA ET CYTOCHEMICA, 59(3), 111-121. https://doi.org/10.1267/ahc.26-00005
Vancouver
Nazar FH, Arrozi AP, Kato T, Yanagisawa D, Itoh Y, Tooyama I, et al. Nuclear Speckle Protein SRRM2 Co-localized with Pathological Tau (pTauS396) in Neuronal and Glial Cells in Progressive Supranuclear Palsy. ACTA HISTOCHEMICA ET CYTOCHEMICA. 2026;59(3):111-121. doi:10.1267/ahc.26-00005
BibTeX
@article{Nazar2026,
author = {Nazar, Faris Hazwan and Arrozi, Aslina Pahrudin and Kato, Tomoko and Yanagisawa, Daijiro and Itoh, Yasushi and Tooyama, Ikuo and Bellier, Jean-Pierre},
title = {Nuclear Speckle Protein SRRM2 Co-localized with Pathological Tau (pTauS396) in Neuronal and Glial Cells in Progressive Supranuclear Palsy},
journal = {ACTA HISTOCHEMICA ET CYTOCHEMICA},
year = {2026},
volume = {59},
number = {3},
pages = {111--121},
doi = {10.1267/ahc.26-00005}
}
EUVIMED